相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Reduced-intensity conditioning in children: a reappraisal in 2008
I. Yaniv et al.
BONE MARROW TRANSPLANTATION (2008)
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population
J. E. Levine et al.
BONE MARROW TRANSPLANTATION (2008)
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant
B. E. Shaw et al.
BONE MARROW TRANSPLANTATION (2008)
Using allogeneic stem cell/T-cell grafts to cure hematologic malignancies
Andrew R. Rezvani et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases
P. Satwani et al.
BONE MARROW TRANSPLANTATION (2008)
Outcomes after allogenic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
Mohamed L. Sorror et al.
BLOOD (2008)
Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders
L. M. Burroughs et al.
BONE MARROW TRANSPLANTATION (2007)
Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases
M. B. Bradley et al.
BONE MARROW TRANSPLANTATION (2007)
Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents
A. J. Barrett et al.
LEUKEMIA (2006)
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation
Frederic Baron et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Correlation of minimal residual disease by assessing Wilms tumor gene expression and engraftment by variable number of tandem repeats in children with leukemia posthematopoietic stem cell transplantation
Marie Olszewski et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2006)
Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors
MA Pulsipher et al.
PEDIATRIC BLOOD & CANCER (2006)
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML
B Horn et al.
BONE MARROW TRANSPLANTATION (2006)
Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis
N Cooper et al.
BLOOD (2006)
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis
BL Scott et al.
LEUKEMIA (2006)
Reduced intensity transplants (RIT) in pediatrics: A review
M Kletzel et al.
PEDIATRIC TRANSPLANTATION (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia
E Roman et al.
CLINICAL CANCER RESEARCH (2005)
Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
M Steiner et al.
BONE MARROW TRANSPLANTATION (2005)
Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning
P Veys et al.
BONE MARROW TRANSPLANTATION (2005)
A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders
S Shenoy et al.
BONE MARROW TRANSPLANTATION (2005)
Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003
MA Pulsipher et al.
BONE MARROW TRANSPLANTATION (2005)
Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen
K Rao et al.
BLOOD (2005)
Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease
A Claviez et al.
ANNALS OF HEMATOLOGY (2004)
A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients
G Del Toro et al.
BONE MARROW TRANSPLANTATION (2004)
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant
M Eapen et al.
BONE MARROW TRANSPLANTATION (2004)
Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents:: The histocompatibility and alternate stem cell source working committee of the International Bone Marrow Transplant Registry
M Eapen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children
DA Jacobsohn et al.
LANCET (2004)
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia
R Iannone et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia
N Goulden et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Reduced-intensity stem cell transplantation in children and adolescents:: The Mexican experience
D Gómez-Almaguer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia
S Meshinchi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL
P Bader et al.
LEUKEMIA (2002)
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children
AE Woolfrey et al.
BLOOD (2002)
Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease
M Schleuning et al.
EXPERIMENTAL HEMATOLOGY (2002)
Nonmyeloablative transplantation in children - Current status and future prospects
MA Pulsipher et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2001)
Bone marrow transplantation without myeloablation for sickle cell disease.
L Krishnamurti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation
BR Dey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed
O Ringdén et al.
BONE MARROW TRANSPLANTATION (2000)
Second allogeneic transplantation after failure of first autologous transplantation
JP Radich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)